(3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid

C50H72N14O10 — CID 149206102

IUPAC(3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid
SMILESCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H]1CCCCNC(=O)C[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)CC(=O)[C@H](CCCN=C(N)N)CC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O
InChIInChI=1S/C50H72N14O10/c1-29(65)60-36(17-10-22-58-50(54)55)45(70)61-37-16-7-8-20-56-43(68)27-40(48(73)74)64-44(69)32(24-33-28-59-35-15-6-5-14-34(33)35)26-41(66)31(13-9-21-57-49(52)53)25-42(67)39(23-30-11-3-2-4-12-30)63-47(72)38(18-19-51)62-46(37)71/h2-6,11-12,14-15,28,31-32,36-40,59H,7-10,13,16-27,51H2,1H3,(H,56,68)(H,60,65)(H,61,70)(H,62,71)(H,63,72)(H,64,69)(H,73,74)(H4,52,53,57)(H4,54,55,58)/t31-,32-,36+,37+,38+,39-,40+/m1/s1
InChIKeyXFQGSWGACYVASB-GDDQEHQVSA-N
MW1029.21 g/mol
LogP-1.22
Rot. Bonds18

About (3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid

(3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid (PubChem CID 149206102) has the molecular formula C50H72N14O10 and a molecular weight of 1029.21 g/mol. Its IUPAC name is (3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid.

Molecular Properties

Compound Name(3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid
PubChem CID149206102
Molecular FormulaC50H72N14O10
Molecular Weight1029.21 g/mol
Exact Mass1028.56
IUPAC Name(3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid
SMILESCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H]1CCCCNC(=O)C[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)CC(=O)[C@H](CCCN=C(N)N)CC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O
InChIInChI=1S/C50H72N14O10/c1-29(65)60-36(17-10-22-58-50(54)55)45(70)61-37-16-7-8-20-56-43(68)27-40(48(73)74)64-44(69)32(24-33-28-59-35-15-6-5-14-34(33)35)26-41(66)31(13-9-21-57-49(52)53)25-42(67)39(23-30-11-3-2-4-12-30)63-47(72)38(18-19-51)62-46(37)71/h2-6,11-12,14-15,28,31-32,36-40,59H,7-10,13,16-27,51H2,1H3,(H,56,68)(H,60,65)(H,61,70)(H,62,71)(H,63,72)(H,64,69)(H,73,74)(H4,52,53,57)(H4,54,55,58)/t31-,32-,36+,37+,38+,39-,40+/m1/s1
InChIKeyXFQGSWGACYVASB-GDDQEHQVSA-N
XLogP-1.22
TPSA416.65 Ų
H-Bond Donors13
H-Bond Acceptors12
Rotatable Bonds18
Heavy Atoms74
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001029.21
LogP ≤ 5-1.22
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze (3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid?
The IUPAC name of (3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid (CID 149206102) is (3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid.
What is the SMILES notation for (3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid?
The canonical SMILES for (3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid is CC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H]1CCCCNC(=O)C[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)CC(=O)[C@H](CCCN=C(N)N)CC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O.
What is the InChIKey of (3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid?
The InChIKey is XFQGSWGACYVASB-GDDQEHQVSA-N. The full InChI is InChI=1S/C50H72N14O10/c1-29(65)60-36(17-10-22-58-50(54)55)45(70)61-37-16-7-8-20-56-43(68)27-40(48(73)74)64-44(69)32(24-33-28-59-35-15-6-5-14-34(33)35)26-41(66)31(13-9-21-57-49(52)53)25-42(67)39(23-30-11-3-2-4-12-30)63-47(72)38(18-19-51)62-46(37)71/h2-6,11-12,14-15,28,31-32,36-40,59H,7-10,13,16-27,51H2,1H3,(H,56,68)(H,60,65)(H,61,70)(H,62,71)(H,63,72)(H,64,69)(H,73,74)(H4,52,53,57)(H4,54,55,58)/t31-,32-,36+,37+,38+,39-,40+/m1/s1.
What are the key properties of (3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid?
(3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid has a molecular weight of 1029.21 g/mol, XLogP of -1.22, 18 rotatable bonds, 13 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,6S,14S,17R,20R,23R)-6-[[(2S)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-3-(2-aminoethyl)-23-benzyl-20-[3-(diaminomethylideneamino)propyl]-17-(1H-indol-3-ylmethyl)-2,5,12,16,19,22-hexaoxo-1,4,11,15-tetrazacyclotricosane-14-carboxylic acid is sourced from PubChem (CID 149206102), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).